The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Sawhney, Sunjeet
    Ceo born in May 1978
    Individual (5 offsprings)
    Officer
    2021-11-16 ~ now
    OF - Director → CIF 0
  • 2
    Parekh, Rajesh
    General Partner born in July 1960
    Individual (18 offsprings)
    Officer
    2021-11-16 ~ now
    OF - Director → CIF 0
Ceased 1
  • Terkko Health Hub, Haartmaninkatu 4, Helsinki, Finland
    Corporate
    Officer
    2021-11-16 ~ 2021-11-16
    PE - Director → CIF 0
parent relation
Company in focus

RAPPTA THERAPEUTICS (UK) LTD

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Average Number of Employees
22022-12-01 ~ 2023-11-30
22021-11-16 ~ 2022-11-30
Debtors
Current
1,082,306 GBP2023-11-30
577,013 GBP2022-11-30
Cash at bank and in hand
205,155 GBP2023-11-30
295,952 GBP2022-11-30
Current Assets
1,287,461 GBP2023-11-30
872,965 GBP2022-11-30
Creditors
Current, Amounts falling due within one year
-1,229,746 GBP2023-11-30
-845,495 GBP2022-11-30
Net Current Assets/Liabilities
57,715 GBP2023-11-30
27,470 GBP2022-11-30
Total Assets Less Current Liabilities
57,715 GBP2023-11-30
27,470 GBP2022-11-30
Net Assets/Liabilities
57,715 GBP2023-11-30
27,470 GBP2022-11-30
Equity
Called up share capital
100 GBP2023-11-30
100 GBP2022-11-30
Retained earnings (accumulated losses)
57,615 GBP2023-11-30
27,370 GBP2022-11-30
Equity
57,715 GBP2023-11-30
27,470 GBP2022-11-30
Prepayments/Accrued Income
Current
1,082,306 GBP2023-11-30
577,013 GBP2022-11-30
Amounts owed to group undertakings
Current
1,177,524 GBP2023-11-30
808,995 GBP2022-11-30
Corporation Tax Payable
Current
14,614 GBP2023-11-30
6,701 GBP2022-11-30
Taxation/Social Security Payable
Current
18,252 GBP2023-11-30
19,401 GBP2022-11-30
Accrued Liabilities/Deferred Income
Current
19,356 GBP2023-11-30
10,398 GBP2022-11-30
Creditors
Current
1,229,746 GBP2023-11-30
845,495 GBP2022-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-11-30
100 shares2022-11-30
Par Value of Share
Class 1 ordinary share
1.002022-12-01 ~ 2023-11-30

  • RAPPTA THERAPEUTICS (UK) LTD
    Info
    Registered number 13746464
    Eighth Floor 6 New Street Square, New Fetter Lane, London EC4A 3AQ
    Private Limited Company incorporated on 2021-11-16 (3 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.